HR19042

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HR19042, covering 2025-03-24 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. [Phase 2]

See pricing